Medicare patients who accessed opioid use disorder treatment through telehealth services during the pandemic were more likely to stay in treatment and less likely to experience an overdose than patients without telehealth access to OUD treatment, according to a federal study published last week in JAMA Psychiatry.

“Telehealth is a valuable service and when coupled with medications for opioid use disorder can be lifesaving,” said Wilson Compton, M.D., deputy director of the National Institute on Drug Abuse and senior author of the study. “This study adds to the evidence showing that expanded access to these services could have a longer-term positive impact if continued.”

Headline
The Health Resources and Services Administration announced Sept. 22 that it will award $19 million in grants to expand various telehealth learning services.…
Headline
The Substance Abuse and Mental Health Services Administration announced Sept. 18 that it awarded $42.3 million in grants to states and territories to support…
Headline
The Centers for Medicare & Medicaid Services Sept. 15 announced an expansion of its outcome-aligned payment model offering technology-supported care to…
Headline
The House Energy and Commerce Subcommittee on Health held a hearing Sept. 15 to discuss more than a dozen legislative proposals regarding Medicare provider…
Blog
To reduce suicide in the healthcare workforce, hospitals and health systems must create an environment where workers feel safe asking for help.By Susan…
Headline
The Department of Health and Human Services announced Sept. 8 through the Substance Abuse and Mental Health Services Administration that it will award $383.4…